 Observational studies of systemic hormone replacement therapy after breast cancer are generally reassuring.If hormone replacement is necessary after breast cancer, estrogen-only therapy or estrogen therapy with an intrauterine device with progestogen may be safer options than combined systemic therapy.Treatments are being evaluated in trials.